3D BioFibR: Funding, Investors & Team (Sep 2026)
3D BioFibR is a company that specializes in the production of biomaterials. They create high-value bio fibers like spider silk, collagen, and chitosan using natural sources. These fibers have shown great potential in various global markets, including biomedical engineering, green textiles, defense, and aerospace engineering. The company was established in July 2020 and is built upon the groundbreaking research of Dr. John Frampton. 3D BioFibR focuses on developing innovative and exclusive methods for manufacturing biofibers on a large scale with unmatched quality. Through their research, they have successfully produced CollaFibR™, collagen fibers that surpass the strength of natural tendons, and spider silk that is stronger than steel and exceptionally flexible. Their ultimate goal is to become the leading global producer of nature's strongest, lightest, and toughest materials, providing cost-effective solutions to current engineering challenges.
3D BioFibR has raised $7.0M across 3 funding rounds on record, the most recent a Seed of $3.0M announced in Jun 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
3D BioFibR Company Profile and Key Stats
Latest funding round on record: Jun 2025.
3D BioFibR Funding Rounds
3D BioFibR raised $2.7M in a Seed announced in Jul 2023.
6 months later, an undisclosed round of $1.3M was announced in Jan 2024.
1.4 years later, a Seed of $3.0M was announced in Jun 2025.
3D BioFibR Founders and Leadership Team
Contact details for the 3D BioFibR team: 1 of 1 has an email address on file.
Start 14-day free trial →3D BioFibR Funding Compared to Other Biotechnology Startups
3D BioFibR's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like 3D BioFibR in Biotechnology and Halifax
Companies Similar to 3D BioFibR
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
3D BioFibR Funding FAQs
What does 3D BioFibR do?
3D BioFibR is a company that specializes in the production of biomaterials. They create high-value bio fibers like spider silk, collagen, and chitosan using natural sources. These fibers have shown great potential in various global markets, including biomedical engineering, green textiles, defense, and aerospace engineering. The company was established in July 2020 and is built upon the groundbreaking research of Dr. John Frampton. 3D BioFibR focuses on developing innovative and exclusive methods for manufacturing biofibers on a large scale with unmatched quality. Through their research, they have successfully produced CollaFibR™, collagen fibers that surpass the strength of natural tendons, and spider silk that is stronger than steel and exceptionally flexible. Their ultimate goal is to become the leading global producer of nature's strongest, lightest, and toughest materials, providing cost-effective solutions to current engineering challenges.
How much funding has 3D BioFibR raised?
3D BioFibR has raised $7.0M across 3 rounds on record. The most recent is a Seed of $3.0M announced in Jun 2025.
When did 3D BioFibR last raise funding?
3D BioFibR's most recent funding round on record is a Seed of $3.0M, announced in Jun 2025.
Who founded 3D BioFibR?
FundedIQ lists Kevin Sullivan (Founder) at 3D BioFibR.
Where is 3D BioFibR headquartered?
3D BioFibR is based in Halifax, Nova Scotia, Canada.
How many employees does 3D BioFibR have?
3D BioFibR is in the 1-10 employee band.
How does 3D BioFibR's funding compare to other Biotechnology startups?
3D BioFibR's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's 3D BioFibR Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for 3D BioFibR is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.